Loperamide inhibits gallbladder inflammatory fluid secretion in experimental cholecystitis

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Fluid secretion by gallbladder mucosa plays a role in acute cholecystitis, causing gallbladder distension.
• Understanding mechanisms of fluid transport in gallbladder disease is crucial for effective treatment.

Purpose of the Study:

• To investigate the effects of loperamide on gallbladder function during experimental acute cholecystitis.
• To explore the potential role of opiate receptors in gallbladder fluid secretion and motility.

Main Methods:

• In vivo study using a continuous perfusion technique in cats.
• Induction of experimental cholecystitis to model the disease state.
• Administration of loperamide and naloxone to assess their effects on gallbladder fluid transport and motility.

Main Results:

• Gallbladder mucosa exhibited net fluid secretion in experimental cholecystitis, unlike control animals showing net fluid absorption.
• Loperamide (1 mg/kg) significantly inhibited the net fluid secretion in experimental cholecystitis.
• The inhibitory effect of loperamide was blocked by naloxone (1 mg/kg), indicating involvement of opiate receptors.
• Loperamide relaxed normal gallbladder but did not affect fluid absorption in healthy gallbladders.

Conclusions:

• Loperamide effectively reduces gallbladder mucosal fluid secretion in experimental acute cholecystitis.
• The mechanism involves peripheral opiate receptors.
• Loperamide shows potential as a therapeutic agent for acute cholecystitis by mitigating gallbladder distension.